Biotage AB (publ) BIOT.ST Stock
Biotage AB (publ) Price Chart
Biotage AB (publ) BIOT.ST Financial and Trading Overview
| Biotage AB (publ) stock price | 170.3 SEK |
| Previous Close | 158 SEK |
| Open | 158 SEK |
| Bid | 158.4 SEK x 0 |
| Ask | 158.4 SEK x 0 |
| Day's Range | 156.9 - 161.5 SEK |
| 52 Week Range | 113.6 - 226.2 SEK |
| Volume | 223.49K SEK |
| Avg. Volume | 224.91K SEK |
| Market Cap | 10.77B SEK |
| Beta (5Y Monthly) | 0.724521 |
| PE Ratio (TTM) | 44.313725 |
| EPS (TTM) | 3.34 SEK |
| Forward Dividend & Yield | 1.6 (1.02%) |
| Ex-Dividend Date | April 28, 2023 |
| 1y Target Est | 222.67 SEK |
BIOT.ST Valuation Measures
| Enterprise Value | 10.23B SEK |
| Trailing P/E | 44.313725 |
| Forward P/E | 36.2844 |
| PEG Ratio (5 yr expected) | 12.59 |
| Price/Sales (ttm) | 6.986486 |
| Price/Book (mrq) | 6.1840353 |
| Enterprise Value/Revenue | 6.638 |
| Enterprise Value/EBITDA | 30.905 |
Trading Information
Biotage AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.724521 |
| 52-Week Change | -1.73% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 226.2 SEK |
| 52 Week Low | 113.6 SEK |
| 50-Day Moving Average | 138.73 SEK |
| 200-Day Moving Average | 162.19 SEK |
BIOT.ST Share Statistics
| Avg. Volume (3 month) | 224.91K SEK |
| Avg. Daily Volume (10-Days) | 151.59K SEK |
| Shares Outstanding | 66.71M |
| Float | 65.67M |
| Short Ratio | N/A |
| % Held by Insiders | 0.58% |
| % Held by Institutions | 64.88% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.6 |
| Trailing Annual Dividend Yield | 1.01% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4294 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 15.57% |
| Operating Margin (ttm) | 18.17% |
| Gross Margin | 60.15% |
| EBITDA Margin | 21.48% |
Management Effectiveness
| Return on Assets (ttm) | 7.92% |
| Return on Equity (ttm) | 15.27% |
Income Statement
| Revenue (ttm) | 1.54B SEK |
| Revenue Per Share (ttm) | 23.35 SEK |
| Quarterly Revenue Growth (yoy) | -6.50% |
| Gross Profit (ttm) | 948M SEK |
| EBITDA | 331M SEK |
| Net Income Avi to Common (ttm) | 240M SEK |
| Diluted EPS (ttm) | 3.57 |
| Quarterly Earnings Growth (yoy) | -39.39% |
Balance Sheet
| Total Cash (mrq) | 426M SEK |
| Total Cash Per Share (mrq) | 6.46 SEK |
| Total Debt (mrq) | 230M SEK |
| Total Debt/Equity (mrq) | 13.63 SEK |
| Current Ratio (mrq) | 2.743 |
| Book Value Per Share (mrq) | 25.582 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 295M SEK |
| Levered Free Cash Flow (ttm) | 178.98M SEK |
Profile of Biotage AB (publ)
| Country | Sweden |
| State | N/A |
| City | Uppsala |
| Address | Box 8 |
| ZIP | 751 03 |
| Phone | 46 18 56 59 00 |
| Website | https://www.biotage.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 516 |
Biotage AB (publ) provides solution and product in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation product; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, academic, environmental protection, food safety, and agriculture, as well as clinical, forensic, and academic laboratories. It operates in 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Q&A For Biotage AB (publ) Stock
What is a current BIOT.ST stock price?
Biotage AB (publ) BIOT.ST stock price today per share is 170.3 SEK.
How to purchase Biotage AB (publ) stock?
You can buy BIOT.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biotage AB (publ)?
The stock symbol or ticker of Biotage AB (publ) is BIOT.ST.
Which industry does the Biotage AB (publ) company belong to?
The Biotage AB (publ) industry is Medical Instruments & Supplies.
How many shares does Biotage AB (publ) have in circulation?
The max supply of Biotage AB (publ) shares is 80.01M.
What is Biotage AB (publ) Price to Earnings Ratio (PE Ratio)?
Biotage AB (publ) PE Ratio is 50.98802600 now.
What was Biotage AB (publ) earnings per share over the trailing 12 months (TTM)?
Biotage AB (publ) EPS is 3.34 SEK over the trailing 12 months.
Which sector does the Biotage AB (publ) company belong to?
The Biotage AB (publ) sector is Healthcare.
Biotage AB (publ) BIOT.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX_Nordic_Large_Cap_ISK_GI OMXNLCISKGI | 613.85 ISK 4.51 USD |
-0.11
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_DKK_GI OMXNLCDKKGI | 424.43 DKK 62.23 USD |
-0.09
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4086.93 SEK 398.94 USD |
-0.47
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 6954.45 SEK 678.84 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Large_Cap_PI OMXSLCPI | 270.06 SEK 26.36 USD |
-0.04
|
— — | — — | — — | — - | — — |
| OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX Stockholm Benchmark_GI OMXSBGI | 1880.94 SEK 183.6 USD |
+0.12
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_SEK_GI OMXNLCSEKGI | 529.96 SEK 51.73 USD |
+0.39
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_EUR_GI OMXNLCEURGI | 424.25 EUR 463.76 USD |
-0.11
|
— — | — — | — — | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3276.93 SEK 319.87 USD |
-0.07
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2564.43 SEK 250.32 USD |
-0.59
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}